The Use of Recombinant Factor VIIa in the Treatment of Bleeding Disorders: Current and Future Perspective

Japanese Journal of Thrombosis and Hemostasis
doi 10.2491/jjsth.19.422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society on Thrombosis and Hemostasis

Related search

Recombinant Factor VIIa for the Prevention and Treatment of Bleeding in Patients Without Haemophilia

2007English

Case Report: Management of Life-Threatening Oropharyngeal Bleeding With Recombinant Factor VIIa

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis

Clinics and Practice
2015English

Cost Effectiveness of Recombinant Factor VIIa for Treatment of Intracerebral Hemorrhage

BMC Neurology
MedicineNeurology
2008English

Failure of Recombinant Factor VIIa in a Patient With Severe Polymicrobial Sepsis and Postoperative Uncontrolled Intraabdominal Bleeding

BMC Infectious Diseases
Infectious Diseases
2007English

Citrate Artificially Masks the Haemostatic Effect of Recombinant Factor VIIa in Dilutional Coagulopathy

Annals of Hematology
MedicineHematology
2008English

Recombinant Factor VIIa for Uncontrollable Bleeding in Patients With Extracorporeal Membrane Oxygenation: Report on 15 Cases and Literature Review

Critical Care
Critical CareIntensive Care Medicine
2013English

The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2006English

Recombinant Factor VIIa for Reversal of Warfarin Anticoagulation in Intracranial Hemorrhage

Surgery for Cerebral Stroke
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy